Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|August 1, 2007
Targeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitorsMelissa E Boyne, Todd J Sullivan, Christopher W amEnde, et al.
Bioorganic Chemistry|May 28, 2026
New N-(isoxazol-3-yl)-4-(1,3,4-thiadiazol-3(2H)-yl)benzenesulfonamide derivatives as potent Aurora kinases inhibitors: Design, synthesis and anti-proliferative activityBshra A Alsfouk, Hazem Elkady, Walid E Elgammal, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2017
Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responsesGulsum E Muku, Tejas S Lahoti, Iain A Murray, et al.
Natural Product Research|July 3, 2026
Isolation, structure elucidation, and in silico Topoisomerase II inhibition of medicarpins isolated from Alfalfa (Medicago sativa)Ahmed R Hassan, Ahmed Ashour, Marwa Elsbaey, et al.
Cancer Letters|August 31, 2014
A novel selective multikinase inhibitor of ROCK and MRCK effectively blocks cancer cell migration and invasionVijay Pralhad Kale, Jeremy A Hengst, Dhimant H Desai, et al.
RSC Advances|May 8, 2025
New nicotinamide-thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and in silico and in vitro evaluationWalid E Elgammal, Hazem Elkady, Reda G Yousef, et al.
Molecules (Basel, Switzerland)|November 13, 2021
A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing VirusesAaya Nassar, Ibrahim M Ibrahim, Fatma G Amin, et al.
Archiv Der Pharmazie|September 29, 2025
New 1,3,4-Thiadiazole-Based Dual B-Raf/VEGFR-2 Inhibitors With Potential Anti-Breast Activity: Design, Synthesis, In Vitro and In Silico EvaluationsWalid E Elgammal, Hazem Elkady, Hazem A Mahdy, et al.
Biochemical Pharmacology|February 13, 2017
Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancerSamy A F Morad, Traci S Davis, Matthew R MacDougall, et al.
Molecular Pharmacology|December 4, 2010
Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavoneIain A Murray, Colin A Flaveny, Christopher R Chiaro, et al.
Pageof 18